Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug 22:10:896147.
doi: 10.3389/fcell.2022.896147. eCollection 2022.

Neuroendocrine regulations in tissue-specific immunity: From mechanism to applications in tumor

Affiliations
Review

Neuroendocrine regulations in tissue-specific immunity: From mechanism to applications in tumor

Si-Qing Liu et al. Front Cell Dev Biol. .

Abstract

Immune responses in nonlymphoid tissues play a vital role in the maintenance of homeostasis. Lots of evidence supports that tissue-specific immune cells provide defense against tumor through the localization in different tissue throughout the body, and can be regulated by diverse factors. Accordingly, the distribution of nervous tissue is also tissue-specific which is essential in the growth of corresponding organs, and the occurrence and development of tumor. Although there have been many mature perspectives on the neuroendocrine regulation in tumor microenvironment, the neuroendocrine regulation of tissue-specific immune cells has not yet been summarized. In this review, we focus on how tissue immune responses are influenced by autonomic nervous system, sensory nerves, and various neuroendocrine factors and reversely how tissue-specific immune cells communicate with neuroendocrine system through releasing different factors. Furthermore, we pay attention to the potential mechanisms of neuroendocrine-tissue specific immunity axis involved in tumors. This may provide new insights for the immunotherapy of tumors in the future.

Keywords: cancer; neuroendocrine regulation; neuropeptide; neurotransmitter; tissue-specific immunity.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Neuroendocrine factors play various role in tissue immune regulation. A variety of neuroendocrine factors play regulatory roles in tissue-resident immune cells. The target cells and their receptors for different factors are displayed in the figure. On the left, neuroendocrine factors are classified according to their function. ACh, GABA, CGRP and TAFA4 mainly play a pro-inflammatory function. DA, 5-HT, NPFF, NMU, PACAP, VIP, NPY, and SP mainly play an anti-inflammatory function. NE plays different roles in different target cells. On the right side of the figure, we marked the functions of NE.

Similar articles

Cited by

References

    1. Abad C., Tan Y. V. Immunomodulatory roles of PACAP and VIP: Lessons from knockout mice. J. Mol. Neurosci. 2018;66(1):102–113.10.1007/s12031-018-1150-y - DOI - PubMed
    1. Agrawal I., Sharma N., Saxena S., Arvind S., Chakraborty D., Chakraborty D. B., et al. Dopamine induces functional extracellular traps in microglia. iScience. 2021;24(1):101968.10.1016/j.isci.2020.101968 - DOI - PMC - PubMed
    1. Albo D., Akay C. L., Marshall C. L., Wilks J. A., Verstovsek G., Liu H., et al. Neurogenesis in colorectal cancer is a marker of aggressive tumor behavior and poor outcomes. Cancer. 2011;117(21):4834–4845.10.1002/cncr.26117 - DOI - PubMed
    1. Aloe L., Rocco M. L., Balzamino B. O., Micera A. Nerve growth factor: Role in growth, differentiation and controlling cancer cell development. J. Exp. Clin. Cancer Res. 2016;35(1):116.10.1186/s13046-016-0395-y - DOI - PMC - PubMed
    1. an J., Feng L., Ren J., Li Y., Li G., Liu C., et al. Chronic stress promotes breast carcinoma metastasis by accumulating myeloid-derived suppressor cells through activating β-adrenergic signaling. Oncoimmunology. 2021;10(1):2004659.10.1080/2162402x.2021.2004659 - DOI - PMC - PubMed

LinkOut - more resources